Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.20%
- Poor long term growth as Net Sales has grown by an annual rate of 0.21% and Operating profit at -208.74% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Sep 25
3
Risky -
4
Below par performance in long term as well as near term
Stock DNA
Software Products
CNY 4,165 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.02
-9.04%
5.00
Revenue and Profits:
Net Sales:
62 Million
(Quarterly Results - Mar 2026)
Net Profit:
4 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.56%
0%
7.56%
6 Months
-6.12%
0%
-6.12%
1 Year
9.1%
0%
9.1%
2 Years
56.43%
0%
56.43%
3 Years
-5.34%
0%
-5.34%
4 Years
-12.61%
0%
-12.61%
5 Years
-59.65%
0%
-59.65%
Suzhou MedicalSystem Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.21%
EBIT Growth (5y)
-208.74%
EBIT to Interest (avg)
0.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.29
Tax Ratio
9.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.20%
ROE (avg)
2.28%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.40
EV to EBIT
-30.18
EV to EBITDA
-49.25
EV to Capital Employed
5.45
EV to Sales
13.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-18.07%
ROE (Latest)
-20.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
61.70
62.20
-0.80%
Operating Profit (PBDIT) excl Other Income
4.20
12.00
-65.00%
Interest
2.90
4.20
-30.95%
Exceptional Items
0.00
0.10
-100.00%
Consolidate Net Profit
4.20
24.90
-83.13%
Operating Profit Margin (Excl OI)
67.30%
97.80%
-3.05%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -0.80% vs -43.56% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -83.13% vs 132.71% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
299.60
461.60
-35.10%
Operating Profit (PBDIT) excl Other Income
48.90
-154.30
131.69%
Interest
13.10
72.20
-81.86%
Exceptional Items
0.10
-31.30
100.32%
Consolidate Net Profit
41.50
-277.60
114.95%
Operating Profit Margin (Excl OI)
56.10%
-544.70%
60.08%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -35.10% vs -24.96% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 114.95% vs -4.68% in Dec 2024
About Suzhou MedicalSystem Technology Co., Ltd. 
Suzhou MedicalSystem Technology Co., Ltd.
Software Products
No Details Available.
Company Coordinates 
No Company Details Available






